Skip to search formSkip to main contentSkip to account menu

Sandimmune

Known as: Sandimmun 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
BACKGROUND The oral formulation of cyclosporin A (CsA)-Sandimmun-has a highly variable absorption. The development of a CsA… 
Highly Cited
1997
Highly Cited
1997
Cyclosporin A (CyA) is a potent immunosuppressive drug which has shown efficacy in various skin disorders. The bioavailability of… 
1993
1993
Summary Data on the use of oral cyclosporin A (CyA; Sandimmun®) therapy for severe adult atopic dermatitis have accumulated since… 
Review
1992
Review
1992
Summary Human studies using oral cyclosporin A (CyA; Sandimmun®) therapy for psoriasis have been in progress for nearly 9 years… 
Highly Cited
1991
Highly Cited
1991
Summary Fourteen patients with severe chronic atopic dermatitis wer treated with cyclosporin A (CyA. Sandimmun® 5 mg/kg/day) for… 
Highly Cited
1989
Highly Cited
1989
Cyclosporin A (ciclosporin), a potent and clinically important immunosuppressive drug (Sandimmun), represents the main component…